7.Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline [J]. Eur Respir J, 2020, 56(1): 200053.DOI: org/10.1183/13993003.00535-2020...
预防、预后、日常生活tips：NTM Lung Disease: Causes, Symptoms & Treatment
Yuji?Shiraishi .Surgical treatment of nontuberculous mycobacterial lung disease. August 2014, Volume 62, Issue 8, pp 475-480 作者认为,肺结核流行性在减小,而肺NTM在增加。虽然,肺NTM 不具备传染性,但是它仍可导致广泛的肺实质破坏,造成呼吸衰竭和气道感染。因此,肺NTM正在变成一个非常明显的健康问题。 因...
1、NTM的诊断和治疗 北京协和医院呼吸科 赵静 1. Ryu YJ, Koh WJ and Daley CL. Diagnosis and treatment of Nontuberculous Mycobacterial Lung disease: Clinicians Perspectives. Tuberc Respir Dis, 2016; 79: 74-84. 2007 2. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An Official ATS/IDSA ...
原文出处:ARIKAYCE® (amikacin liposome inhalation suspension)approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients with NTM Lung Disease Caused by MAC Who Did Not Sufficiently Respond to Prior Treatment with MDR...
Recently, there has been an increase in NTM pulmonary disease in immunocompetent adults.The pathogenic potential, prevalence & treatment of diseases can vary, identifying pathogens is essential for accurate diagnosis and appropriate management.👉 Learn more: O网页链接#Seegene #NontuberculousMycobacteria ...
The latest information about nontuberculous mycobacterial (NTM) lung disease for healthcare professionals, and how it affects bronchiectasis, COPD, and asthma patients.
If you have nontuberculous mycobacterial lung disease, use this guide as a starting point for your next doctor visit. Ask about symptoms, treatment, and living with this condition.
Abstract:Objective To analyze the strain distribution and clinical characteristics of non-tuberculous Mycobacterium(NTM)lung disease patients in Tianjin area,and to provide reference for clinical diagnosis and treatment of NTM lung disease in Tianjin area.Methods A total of106patients with NTM pulmonary ...
RESULTS: Clinical and radiographic findings that were more common in patients with NTM lung disease than in PTB patients were: older age ( P < 0.001), non-smoker ( P < 0.001), history of previous TB treatment ( P < 0.001), absence of pleural effusion ( P = 0.017), involvement of ...